Alarming Surge in Alcohol-Related Liver Transplants in Younger Adults Targeted preventive strategies needed, especially for younger women, researchers say Nov 14, 2024
GLP-1 Drugs Could Help People With Alcohol Use Disorder Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations Nov 13, 2024
FDA Rejects Full Approval of Liver Disease Drug Agency's decision on obeticholic acid in PBC follows negative advisory committee meeting Nov 12, 2024
Rifaximin Reduced Overt Hepatic Encephalopathy Recurrence Over Lactulose Rifaximin also reduced mortality, but its high cost may be a barrier Nov 01, 2024
Algorithm May Be Able to Predict HCC Risk in Advanced Chronic Liver Disease Easy to apply, uses parameters commonly measured in outpatient and inpatient settings Oct 25, 2024
Rainfall and Mortality; Identifying Risk for Preeclampsia Also in TTHealthWatch: HIV-positive kidney donors Oct 19, 2024 podcast
Novel Drug Effective Against MASH in Phase II Trial Fatty acid synthase inhibitor targets main drivers of liver injury Oct 14, 2024
GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Death Limited benefit seen in patients with established cirrhosis, however Sep 16, 2024
Another Possible Treatment Option for Intermediate-Stage Liver Cancer Adding lenvatinib, pembrolizumab to TACE significantly improved PFS, numerically improved OS Sep 16, 2024
Approved Liver Disease Drug Has No Clinical Benefit, FDA Panel Says Agency advisors put their foot down on shaky science for Ocaliva in primary biliary cholangitis Sep 13, 2024
FDA Warning on Hot Flash Drug Clinicians should perform liver blood tests before and during Veozah treatment Sep 12, 2024
FDA Reviewers Skeptical of Ocaliva for Rare Bile Duct Disease Agency advisory panel to examine complicated efficacy data and liver safety concerns Sep 11, 2024
Women With HCC Less Likely to Receive Liver Transplant, More Likely to Die Than Men This difference is mostly explained by their smaller stature, researchers say Sep 05, 2024
Rate of Mortality After ED Discharge for Cirrhosis Doubles That of Heart Failure Patients who lacked a follow-up visit may be at particularly high risk for death Aug 28, 2024
Amino Acids May Protect Kidneys During Surgery; EDTA for Chelation Therapy Also in TTHealthWatch: suicidality among spouses of people with cancer Aug 24, 2024 podcast
No Effect of Tranexamic Acid on Bleeding in Surgery for Liver Cancer No difference from placebo in transfusion rate, blood loss, with higher complication rate Aug 19, 2024
FDA OKs New Option for Primary Biliary Cholangitis Seladelpar improved biochemical response, ALP normalization versus placebo in phase III trial Aug 14, 2024
Millions of Americans Use Potentially Hepatotoxic Botanical Products And liver injuries tied to herbal and dietary supplements are on the rise, data show Aug 05, 2024
Which Anticoagulant Is Safest for Afib Patients With Cirrhosis? National cohort study finds up to 47% fewer serious hemorrhagic events with one agent Jul 08, 2024
Aspirin Overuse; Biotypes of Depression and Anxiety Also in TTHealthWatch: medications and the liver, and managing gestational diabetes Jun 30, 2024 podcast
FDA OKs First Point-of-Care Test for Detecting Hep C in At-Risk Adults Results as quick as 1 hour, enabling a test-and-treat approach Jun 27, 2024
Real-World Analysis Identifies Meds Tied to Higher Risk of Liver Injury Case reports may not be as reliable, researchers say Jun 25, 2024
Novel GLP-1/Glucagon Drug Promising for Weight Loss Phase II data support testing pemvidutide for comorbid obesity and liver conditions Jun 24, 2024
Nanoliposomal Irinotecan Fails to Boost Survival in Treated Advanced Biliary Cancer No difference in PFS, median OS favored control group Jun 12, 2024
Testosterone Prodrug Improves Muscle Mass, Encephalopathy in Men With Cirrhosis Androgen precursor may help cirrhosis-related sarcopenia Jun 11, 2024
Rifaximin Prophylaxis Fails for Bacterial Peritonitis in Cirrhotic Patients "Is it time to say primary prophylaxis is dead?" one expert asks Jun 11, 2024
Novel Drug for Rare Chronic Liver Disease Wins Conditional FDA Approval First-in-class PPAR agonist led to biochemical responses in more than 50% of patients in trial Jun 11, 2024
Patients With Severe ACLF on Liver Transplant Waitlists Face High Mortality Rates Urgent need for organ allocation system reform, researchers say Jun 09, 2024
Weight Loss/Diabetes Drug Has Positive Treatment Effect on MASH GLP-1/GIP agonist also improved fibrosis biomarkers, liver fat, and stiffness in phase II trial Jun 08, 2024
Novel Glucagon/GLP-1 Receptor Dual Agonist Improved MASH in Phase II Study Effects may be related to weight loss, not changes in fibrogenesis, expert suggests Jun 07, 2024
Novel Intelligent Liver Function Test Platform Improves Liver Disease Diagnosis iLFT is now an essential, highly utilized tool at one U.K. primary care system Jun 07, 2024
Bulevirtide/Pegylated Interferon Combo Beats Monotherapy for Chronic Hepatitis D Combo therapies for HDV with drugs other than pegylated interferon would be better, expert says Jun 06, 2024
Changes to Liver Transplant Policy Increased Costs in Vulnerable Areas Hospital costs increased 12% in low-income areas vs 5.1% in high-income areas May 29, 2024
FDA Withdraws Approval of FGFR Inhibitor for Bile Duct Cancer Sponsor for infigratinib (Truseltiq) failed to recruit and enroll patients in confirmatory study May 20, 2024
Resection for Early Liver Cancer Tied to Improved Survival 5-year OS rate nearly doubled vs nonsurgical approaches for early HCC, retrospective study finds May 15, 2024
Liver Disease, High Lipoprotein(a) Tied to Higher MI Risk in Diabetes Patients Sixfold increased risk of non-fatal MI among patients with highest levels of Lp(a) May 13, 2024
Are Health Workers More Prone to Alcohol-Related Death? No, and physicians appear to have the lowest risk May 08, 2024
Rare Pregnancy Problem Linked to Thiopurines, FDA Says Agency finds risk for intrahepatic cholestasis of pregnancy mostly in IBD, lupus patients May 03, 2024
Liver Cancer Screening Benefits Patients With Cirrhosis, Study Suggests Analysis still finds improved survival after correcting for lead- and length-time biases May 01, 2024
